Cardiomyopathy Trial, Recruiting NCT07617844 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT07617844
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older, of any gender.
  • People who have a suspected or confirmed heart condition (such as blocked arteries in the heart, heart muscle disease, heart inflammation, or heart valve problems) where a cardiac MRI scan is needed to understand the cause or assess the heart muscle.
  • People who have no medical reasons preventing them from having an MRI scan, and who are able to hold their breath as instructed during the scan.
  • People who are willing to take part and sign a consent form agreeing to join the study.

Who may not be able to join:

  • People who have certain metal implants in their body that are not safe for MRI, such as older-style pacemakers, implantable heart defibrillators, or certain surgical clips used for brain aneurysms.
  • People with severe claustrophobia (extreme fear of enclosed spaces) that cannot be managed enough to complete the MRI scan.
  • People with severely reduced kidney function.
  • Women who are pregnant or breastfeeding.
  • People with serious irregular heart rhythms (for example, persistent atrial fibrillation) that would make the MRI images too poor in quality to be useful for diagnosis.
  • People who are unlikely to be able to attend follow-up appointments, or who the trial investigators consider unsuitable for the study for other reasons.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 15267029492

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic Efficacy of Multi-modal CMR Parameters (AUC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov